Clarivate

AUGUST 17, 2022

In our latest podcast, Ideas to Innovation, we speak with Dr. Grace Lomax, the clinical director at Patient Connect, part of Clarivate. In 2017, the same year the SDGs came into effect, the United Nations found that less than half of the global population was covered by essential health services. Dr. Grace Lomax.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

European Pharmaceutical Review

MARCH 24, 2023

Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) side effects. This is important for a condition that requires chronic treatment, as poor GI tolerability could adversely affect patients’ quality of life, adherence to treatment and clinical outcomes.

Medical 108

Medical Side effects Safety Pharmaceutical 108

pharmaphorum

SEPTEMBER 16, 2022

UK-based George Medicines is running a phase 3 trial of GMRx2 – a low-dose formulation of established blood pressure drugs telmisartan, amlodipine, and indapamide – involving 1,500 patients across seven countries. By 2030, it is projected that over 215 million Africans will have hypertension.

Side effects 52

Side effects Medicine Healthcare Provider Patients 52

pharmaphorum

DECEMBER 21, 2022

Likewise, between 2030 and 2050, the World Health Organization estimates that climate change will be responsible for around 250,000 additional deaths per year. Perhaps this is no surprise – it speaks, after all, to the very heart of the pharmaceutical sector’s purpose: to improve the lives of patients and communities.

Side effects 98

Side effects Healthcare Healthcare Ethics 98

Celeritas

SEPTEMBER 26, 2022

The QR code payment market is projected to rise to $35 billion by 2030. A) Aiding Healthcare Professionals (HCPs): Storage of Patient Information: The common method of use of QR codes is in the organization and accessibility of patient records. In essence, patients’ files are all synced to a medical database.

Physicians 52

Physicians Patients Medical Management 52

European Pharmaceutical Review

OCTOBER 24, 2024

Anti-amyloid beta (Aβ) monoclonal antibody (mAb) donanemab is part of new class of amyloid targeting therapies, and while it can slow Alzheimer’s disease progression by four to seven months, NICE’s independent committee highlighted, they were uncertain about making it available for NHS patients. billion in 2030, respectively.”

Food and Drug Administration 52

Food and Drug Administration Side effects Medicine Patients 52

Clarify Health

OCTOBER 3, 2023

Today, there are some noticeable shifts for the better happening on the digital front, largely driven by healthcare consumerism and the demand that healthcare meet patients where they are – on their phones, in their homes, and outside the hospital. Collecting data outside of a care setting can offer valuable insights into day-to-day health.

Healthcare 59

Healthcare Healthcare Patients Side effects 59

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe side effects. from 2023 to 2030. Poised to grow at a CAGR of 29.4% The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

SEPTEMBER 30, 2022

of patients, while for ARIAH-H the rates were 17% and 0.7%, respectively. He pointed out that services to administer the injections frequently, and the required radiology and clinical monitoring for patients, “will all need to be factored in on top of the simple cost of the drug.” In Clarity AD, the rate of ARIA-E was 12.5%

Doctors 52

Doctors Side effects Sales Safety 52

Celeritas

SEPTEMBER 25, 2022

The QR code payment market is projected to rise to $35 billion by 2030. The hospital waiting room can often have an uncomfortable atmosphere despite the Patient Experience Officer’s best efforts. Here, patients can familiarize themselves with their animal’s caretaker and watch informative or entertaining videos in an easy format.

Insurance 52

Insurance Management Medical Marketing 52

European Pharmaceutical Review

OCTOBER 12, 2022

A Phase III trial evaluating TauRx Therapeutics’ oral drug hydromethylthionine mesylate (HMTM), a tau aggression inhibitor, showed the medication continued to improve cognition over a pre-treatment baseline in patients with early Alzheimer’s for the first time. The safety data from the trial was consistent with earlier trial data.

Side effects 98

Side effects Safety Patients Sales 98

Pharmaceutical Technology

JANUARY 11, 2023

How patients receive treatment is being revolutionised by advancements in AI and machine learning, the internet of things (IoT) and extended reality, coupled with a growing comfort with digital devices including smartphones and telehealth, as a part of managing one’s care. The global market size is estimated to be more than $95.3bn 1.

Healthcare 52

Healthcare Healthcare Medical Electronics 52